PMID: 10604709Dec 22, 1999Paper

Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors

J B NelsonLouis R Kavoussi


To assess retrospectively whether laparoscopic retroperitoneal lymph node dissection (RPLND) in patients with clinical Stage I nonseminomatous germ cell testicular tumor (NSGCT) provides useful pathologic staging information on which subsequent management can be based. Approximately 30% of patients with clinical Stage I NSGCT will have pathologic Stage II disease. A retrospective review of 29 patients with clinical Stage I NSGCT who underwent transperitoneal laparoscopic RPLND by a single surgeon was performed. Selection criteria included the presence of embryonal carcinoma in the primary tumor or vascular invasion. A modified left (n = 18) or right (n = 11) template was used. Positive retroperitoneal nodes were detected in 12 (41%) of 29 patients. Ten of these patients received immediate adjuvant platinum-based chemotherapy, and 2 patients refused chemotherapy. The nodes were negative in 1 7 (59%) of 29 patients; all but 2 patients (one with recurrence in the chest, the other with biochemical recurrence) have undergone observation. No evidence of disease recurrence has been found in the retroperitoneum of any patient (follow-up range 1 to 65 months). Prospectively, the dissection was limited if grossly positive nodes were enco...Continue Reading


Jun 1, 1990·Current Opinion in Oncology·R T Oliver
Oct 1, 1995·The Journal of Urology·J BanielJ P Donohue
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U KeilholzW Hunstein
Nov 17, 1998·The Journal of Urology·L H Einhorn, J P Donohue

❮ Previous
Next ❯


Jul 3, 2008·World Journal of Urology·Patrick A Kenney, Ingolf A Tuerk
May 8, 2008·Surgical Endoscopy·Lewis DiulusSteven Rosenblatt
Aug 28, 2003·Current Treatment Options in Oncology·Surena F Matin
Aug 19, 2005·Current Treatment Options in Oncology·Andrew J Stephenson, Joel Sheinfeld
Feb 9, 2002·Urology·Sam S Chang, Bruce Roth
Jul 9, 2002·Urology·Michael A PaleseLouis R Kavoussi
Feb 14, 2006·Nature Clinical Practice. Urology·Brett S Carver, Joel Sheinfeld
Feb 9, 2008·Journal of Endourology·Octavio A CastilloOscar Cortes
Jan 6, 2005·Journal of Laparoendoscopic & Advanced Surgical Techniques. Part a·Ralph MadebJean V Joseph
Mar 17, 2007·Journal of Laparoendoscopic & Advanced Surgical Techniques. Part a·Endre HolmanMorshed A Salah
Sep 27, 2005·Annals of Surgical Oncology·Brett S Carver, Joel Sheinfeld
Nov 3, 2011·The Urologic Clinics of North America·Ornob P RoyLouis R Kavoussi
Sep 23, 2008·Critical Reviews in Oncology/hematology·D PectasidesG Aravantinos
Mar 30, 2001·The Urologic Clinics of North America·G Janetschek
Mar 13, 2016·Current Urology Reports·Heather J ChalfinMohamad E Allaf
Oct 21, 2009·BJU International·Hannes SteinerGeorg Bartsch
Jul 24, 2004·Urologic Oncology·Andrew J Stephenson, Joel Sheinfeld
Jul 24, 2004·Urologic Oncology·Antonio FinelliInderbir S Gill
Mar 23, 2005·Urology·Mohamad E AllafLouis R Kavoussi
May 9, 2007·The Urologic Clinics of North America·Toni K ChoueiriEric A Klein
May 9, 2007·The Urologic Clinics of North America·Hong Gee SimDaniel W Lin
Oct 21, 2009·BJU International·Andrew J Stephenson, Eric A Klein
Oct 25, 2016·The Journal of Urology·Tyler S BeveridgeNicholas E Power
Mar 11, 2005·Expert Review of Anticancer Therapy·Gerald H YoonDonald G Skinner
Oct 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brett S CarverJoel Sheinfeld
May 7, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joel Sheinfeld, Robert J Motzer
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan OldenburgSophie D Fosså
May 3, 2006·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Frederico R RomeroLouis R Kavoussi
Jun 7, 2006·Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy
Jul 7, 2018·Current Opinion in Urology·Ryan P WerntzScott E Eggener
Jul 25, 2007·Oncology·Dimitrios PectasidesMelina Pectasides

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.